UK ' s NICE Gives Roche Drug Green Light for Bladder Cancer UK ' s NICE Gives Roche Drug Green Light for Bladder Cancer

Britain ' s healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche ' s immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news